MedTrace Logo

Role of Supermicrosurgical LVA for Lower Limb Lymphedema

NCT04698707 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2021-01-07

No results posted yet for this study

Summary

Vascularized lymph node flap transfer (VLNT) was believed to be the treatment of choice for moderate-to-severe lymphedema. Recent publications have supported the use of supermicrosurgical lymphaticovenous anastomosis (LVA) for treating severe lymphedema. This study hypothesizes whether LVA can be performed on post-VLNT patients seeking further improvement.

Conditions

  • Lymphedema

Interventions

OTHER

Vascularized lymph node flap transfer

Patients who have received VLNT as their primary treatment but with minimal improvement

OTHER

Patients without prior lymphedema surgery

Patients without prior lymphedema surgery

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-28
Primary Completion
2020-10-05
Completion
2020-11-19

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04698707 on ClinicalTrials.gov